Drug:
Reaction: ALOPECIA
20260101 - 20261231
No. 201 - 300
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 201 | 26517607 |
US |
2 | |
Alopecia, |
||||
RELUGOLIX, ESTRADIOL HEMIHYDRATE, AND NORETHINDRONE ACETATE, |
||||
| 202 | 26518083 |
BR |
77 | 1 |
Bradycardia, Fatigue, Peripheral coldness, Muscle spasms, Headache, Nausea, Disturbance in attention, Somnolence, Alopecia, Sexual dysfunction, Anxiety, Nervousness, Pulse abnormal, Poor quality sleep, Gait disturbance, |
||||
DAPAGLIFLOZIN, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, INSULIN GLARGINE-YFGN, INSULIN GLARGINE, INSULIN LISPRO, PITAVASTATIN CALCIUM, PITAVASTATIN, OLMESARTAN MEDOXOMIL, AMLODIPINE BESYLATE, EZETIMIBE, |
||||
| 203 | 26518164 |
CA |
44 | 2 |
Abdominal discomfort, Abdominal pain, Abdominal pain upper, Adverse drug reaction, Adverse event, Alopecia, Anti-cyclic citrullinated peptide antibody positive, Arthralgia, Arthropathy, Asthenia, Asthma, Blister, Blood cholesterol increased, Bursitis, C-reactive protein abnormal, Condition aggravated, Confusional state, Diarrhoea, Discomfort, Dizziness, |
||||
LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, RITUXIMAB, RITUXIMAB, RITUXIMAB, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, PREGABALIN, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, OXYCODONE HYDROCHLORIDE, OXYCODONE, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, |
||||
| 204 | 26519319 |
US |
72 | 2 |
Alopecia, |
||||
DOSTARLIMAB, |
||||
| 205 | 26519338 |
US |
2 | |
Enterocolitis viral, Crying, Weight decreased, Fear of falling, Hot flush, Arthralgia, Malaise, Drug effect less than expected, Asthenia, Carpal tunnel syndrome, Constipation, Anaemia, Depression, Dyspepsia, Fatigue, Nausea, Alopecia, Dizziness, Unevaluable event, |
||||
LEVOKETOCONAZOLE, LEVOKETOCONAZOLE, LEVOKETOCONAZOLE, DULOXETINE HYDROCHLORIDE, DULOXETINE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, |
||||
| 206 | 26519469 |
2 | ||
Fatigue, Alopecia, Stomatitis, Fluid retention, |
||||
DATOPOTAMAB DERUXTECAN, |
||||
| 207 | 26519649 |
EU |
2 | |
Haematochezia, Nausea, Diarrhoea, Decreased appetite, Pain in extremity, Vertigo, Dry eye, Taste disorder, Brain fog, Alopecia, Dyspepsia, |
||||
LETROZOLE, LETROZOLE TABLETS, RIBOCICLIB, |
||||
| 208 | 26519728 |
CA |
40 | 2 |
Abdominal discomfort, Alopecia, Confusional state, Decreased appetite, Discomfort, Drug hypersensitivity, Drug ineffective, Drug-induced liver injury, Dry mouth, Epilepsy, Fall, Fatigue, Fibromyalgia, Folliculitis, Gait inability, Gastrointestinal disorder, Gastrooesophageal reflux disease, Glossodynia, Injection site reaction, Nausea, Off label use, Onychomadesis, Pemphigus, Pericarditis, Product use in unapproved indication, Rash, Rheumatic fever, Rheumatoid arthritis, Treatment failure, Urticaria, Wound, |
||||
SECUKINUMAB, SECUKINUMAB, ERENUMAB-AOOE, ERENUMAB-AOOE, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, ESOMEPRAZOLE MAGNESIUM CAPSULE, DELAYED RELEASE, ESOMEPRAZOLE MAGNESIUM DIHYDRATE, ESOMEPRAZOLE MAGNESIUM DELAYED RELEASE CAPSULES, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, OXYCODONE, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, CALCIUM CARBONATE, ANTACID, ERGOCALCIFEROL, TOPIRAMATE, TOPIRAMATE SPINKLE, TRAMADOL HYDROCHLORIDE, VITAMIN A, VITAMIN C, ERGOCALCIFEROL, POVIDONE-IODINE, RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, GOLIMUMAB, |
||||
| 209 | 26520026 |
US |
2 | |
Brain fog, Mood altered, Arthralgia, Alopecia, Libido disorder, Drug ineffective, |
||||
ESTRADIOL, PROGESTERONE, LORATADINE, LORATADINE TABLET, FLUTICASONE PROPIONATE, ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL, ALBUTEROL SULFATE, ALBUTEROL, |
||||
| 210 | 26520121 |
US |
||
Insomnia, Skin irritation, White blood cells urine positive, Alopecia, |
||||
LENIOLISIB, LEVONORGESTREL AND ETHINYL ESTRADIOL, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, FERROUS SULFATE, MINOXIDIL, MINOXIDIL FOAM 5% (WOMENS), CETIRIZINE HYDROCHLORIDE, |
||||
| 211 | 26520382 |
US |
1 | |
Peripheral swelling, Swelling face, Alopecia, Folliculitis, Insomnia, White blood cell count increased, Fatigue, |
||||
VOCLOSPORIN, VOCLOSPORIN, |
||||
| 212 | 26520716 |
US |
65 | 1 |
Onychomadesis, Condition aggravated, Alopecia, |
||||
ROSUVASTATIN, SERTRALINE, CARVEDILOL, |
||||
| 213 | 26520838 |
2 | ||
Metastases to bone, Abdominal discomfort, Feeling hot, Alopecia, Pelvic pain, Back pain, Gait disturbance, |
||||
FAM-TRASTUZUMAB DERUXTECAN-NXKI, FAM-TRASTUZUMAB DERUXTECAN-NXKI, FAM-TRASTUZUMAB DERUXTECAN-NXKI, FAM-TRASTUZUMAB DERUXTECAN-NXKI, |
||||
| 214 | 26512770 |
GB |
60 | |
Arthralgia, Alopecia, Amnesia, |
||||
INFLIXIMAB-DYYB, |
||||
| 215 | 26513138 |
US |
||
Presyncope, Anxiety, Confusional state, Increased appetite, Dizziness, Alopecia, Blood glucose decreased, Drug ineffective, |
||||
TIRZEPATIDE, |
||||
| 216 | 26513154 |
EU |
10 | 2 |
Topical steroid withdrawal reaction, Impaired quality of life, Pruritus, Dermatitis, Depression, Skin atrophy, Anger, Delayed puberty, Alopecia, |
||||
HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, MOMETASONE FUROATE, MOMETASONE, MOMETASONE FUROATE, MOMETASONE, |
||||
| 217 | 26513991 |
CA |
43 | |
Alopecia, Arthropathy, Asthenia, Breast cancer stage III, Bursitis, C-reactive protein increased, Condition aggravated, Confusional state, Duodenal ulcer perforation, Epilepsy, Facet joint syndrome, Fatigue, Fibromyalgia, Hand deformity, Hypertension, Hypoaesthesia, Inflammation, Lip dry, Liver injury, Mobility decreased, Muscle injury, Musculoskeletal pain, Nail disorder, Obesity, Osteoarthritis, Pemphigus, Pericarditis, Psoriatic arthropathy, Rheumatoid arthritis, Stomatitis, Swelling, Systemic lupus erythematosus, Type 2 diabetes mellitus, Urticaria, Wheezing, Lower respiratory tract infection, Wound infection, Nasopharyngitis, Helicobacter infection, Live birth, Maternal exposure during pregnancy, Intentional product use issue, Intentional product use issue, Intentional product use issue, |
||||
RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, ACETAMINOPHEN AND CODEINE, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, ERENUMAB-AOOE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, ATOMOXETINE HYDROCHLORIDE, BOTULINUM TOXIN TYPE A, BOTULINUM TOXIN TYPE A, BUPRENORPHINE, BUPRENORPHINE, CALCIUM CARBONATE, ANTACID, CALCIUM CARBONATE, ANTACID, CALCIUM CARBONATE, ANTACID, CALCIUM CARBONATE, ANTACID, CANDESARTAN, CANDESARTAN, CANDESARTAN, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, SECUKINUMAB, SECUKINUMAB, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DEXPANTHENOL, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, SARILUMAB, SARILUMAB, LAMOTRIGINE, LAMOTRIGINE, OXYCODONE, OXYCODONE, OXYCODONE, OXYCODONE, PYRIDOXINE HYDROCHLORIDE, PYRIDOXINE HYDROCHLORIDE, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, ERGOCALCIFEROL, |
||||
| 218 | 26514191 |
CN |
||
Alopecia, Nausea, Electrocardiogram ST segment abnormal, Supraventricular extrasystoles, Sinus arrhythmia, Atrioventricular block, Electrocardiogram QRS complex abnormal, QRS axis abnormal, Left ventricular hypertrophy, Diarrhoea, Abdominal pain, White blood cell count decreased, Haemoglobin decreased, Platelet count decreased, Hepatic function abnormal, Arthralgia, Anaemia, |
||||
PERTUZUMAB, TRASTUZUMAB, DOCETAXEL, DOCETAXEL ANHYDROUS, CARBOPLATIN, |
||||
| 219 | 26515085 |
CA |
43 | 2 |
Alopecia, Contusion, Folliculitis, Dyspnoea, Gastrointestinal disorder, Ill-defined disorder, Glossodynia, Headache, Hypertension, Impaired healing, |
||||
SECUKINUMAB, RISEDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, PREGABALIN, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, MAGNESIUM, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, CANDESARTAN, ERENUMAB-AOOE, ERENUMAB-AOOE, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, ADALIMUMAB-ADAZ, RITUXIMAB, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, |
||||
| 220 | 26515133 |
US |
2 | |
Alopecia, Overdose, |
||||
MINOXIDIL, |
||||
| 221 | 26515617 |
CA |
43 | 2 |
Abdominal discomfort, Alopecia, Anti-cyclic citrullinated peptide antibody positive, Arthralgia, Arthropathy, Asthma, Blister, Breast cancer stage III, Condition aggravated, Contraindicated product administered, Decreased appetite, Depression, Diarrhoea, Discomfort, Drug hypersensitivity, Drug ineffective, Drug intolerance, Drug tolerance decreased, Duodenal ulcer perforation, Maternal exposure during pregnancy, Fatigue, Fibromyalgia, General physical health deterioration, Glossodynia, Hand deformity, Helicobacter infection, Hypersensitivity, Hepatic enzyme increased, Infusion related reaction, Hypoaesthesia, Joint swelling, Pain, Pemphigus, Pericarditis, Off label use, Product use issue, Rash, Rheumatoid factor positive, Swelling, Synovitis, Systemic lupus erythematosus, Treatment failure, Wound, |
||||
TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, |
||||
| 222 | 26515744 |
JP |
||
Cutaneous T-cell lymphoma, Alopecia, Erythema, |
||||
| 223 | 26516006 |
US |
82 | 2 |
Lacrimation increased, Alopecia, Product dose omission issue, |
||||
PALBOCICLIB, |
||||
| 224 | 26516268 |
US |
64 | 2 |
Heart rate increased, Alopecia, Nausea, Eructation, Injection site erythema, Injection site swelling, Injection site pruritus, Injection site urticaria, |
||||
TIRZEPATIDE, TIRZEPATIDE, |
||||
| 225 | 26516516 |
UM |
23 | 2 |
Alopecia, |
||||
OMALIZUMAB, |
||||
| 226 | 26518634 |
78 | 2 | |
Dry skin, Dry skin, Alopecia, Onychoclasis, Fatigue, |
||||
PALBOCICLIB, |
||||
| 227 | 26518960 |
2 | ||
Fatigue, Headache, Alopecia, Influenza like illness, |
||||
PEGINTERFERON ALFA-2A, |
||||
| 228 | 26507899 |
US |
2 | |
Alopecia, Off label use, |
||||
ROMOSOZUMAB-AQQG, |
||||
| 229 | 26508105 |
US |
||
Alopecia, |
||||
TIRZEPATIDE, |
||||
| 230 | 26508337 |
GN |
33 | 2 |
Ascites, Vomiting, Alopecia, Anorectal disorder, Herpes zoster, Escherichia infection, Weight decreased, Pyrexia, |
||||
PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, DOXORUBICIN HYDROCHLORIDE, DOXORUBICIN, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, |
||||
| 231 | 26508345 |
CO |
23 | 1 |
Hypokalaemia, Insomnia, Gastroenteritis, Urinary tract discomfort, Diarrhoea, Pain, Headache, Feeling of body temperature change, Influenza like illness, Pyrexia, Malaise, Weight decreased, Hypochromic anaemia, Alopecia, Pallor, Dry skin, Pain of skin, Dysuria, Hyperaesthesia, Proteinuria, Sneezing, Headache, Nausea, Palpitations, Dyspnoea, Abdominal pain, Somnolence, Asthenia, Erythema, Malaise, Malaise, Malaise, Body temperature increased, Chills, Pyrexia, Oropharyngeal pain, Cough, Rhinitis, Pain in extremity, Fatigue, Headache, Paraesthesia, Back pain, Hypotension, Tachycardia, Asthenia, Off label use, |
||||
AGALSIDASE BETA, AGALSIDASE BETA, AGALSIDASE BETA, HYDROXYZINE, |
||||
| 232 | 26508692 |
CA |
44 | 2 |
Rash, Pruritus, Pyrexia, Drug hypersensitivity, Rheumatic fever, Rheumatoid arthritis, Rheumatoid factor positive, Road traffic accident, Sinusitis, Sleep disorder, Sleep disorder due to general medical condition, insomnia type, Stomatitis, Swelling, Swollen joint count increased, Synovitis, Systemic lupus erythematosus, Therapeutic product effect decreased, Therapy non-responder, Treatment failure, Type 2 diabetes mellitus, Urticaria, Vomiting, Weight increased, Wheezing, Wound, Alopecia, Anti-cyclic citrullinated peptide antibody positive, Blister, Decreased appetite, Discomfort, |
||||
SECUKINUMAB, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, OXYCODONE, OXYCODONE, OXYCODONE HYDROCHLORIDE, OXYCODONE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, ADALIMUMAB-ADAZ, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, OXYCODONE AND ACETAMINOPHEN, OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN, OXYCODONE AND ACETAMINOPHEN TABLETS, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, VITAMIN C, CALCIUM CARBONATE, ANTACID, |
||||
| 233 | 26508891 |
US |
2 | |
Alopecia, |
||||
TIRZEPATIDE, |
||||
| 234 | 26508935 |
US |
55 | 1 |
Pain of skin, Palmar-plantar erythrodysaesthesia syndrome, Pruritus, Alopecia, Product dose omission issue, |
||||
RIPRETINIB, |
||||
| 235 | 26509158 |
US |
69 | 1 |
Influenza, Oxygen saturation decreased, Diarrhoea, Hyperglycaemia, Glycosylated haemoglobin increased, Dry skin, Alopecia, Pruritus, Dysphonia, Dry mouth, Increased tendency to bruise, Cough, Micturition urgency, Dyspnoea, Fatigue, Nausea, Constipation, Abdominal discomfort, Surgery, Choking, Tooth fracture, Arthropod bite, Hernia, Haemorrhagic diathesis, |
||||
NINTEDANIB, |
||||
| 236 | 26509370 |
US |
57 | 2 |
Alopecia, Drug ineffective, Disease progression, |
||||
PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), PEMBROLIZUMAB, |
||||
| 237 | 26509539 |
US |
53 | 2 |
Alopecia, |
||||
TIRZEPATIDE, TIRZEPATIDE, |
||||
| 238 | 26509581 |
EU |
46 | 2 |
Gastrointestinal disorder, Skin toxicity, Adenocarcinoma of colon, Alopecia, Red blood cell count decreased, Haemoglobin decreased, Haematocrit decreased, Lymphocyte percentage decreased, Red cell distribution width increased, |
||||
PANITUMUMAB, OXALIPLATIN, FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, CAPECITABINE, |
||||
| 239 | 26509759 |
US |
68 | 2 |
Paraesthesia, Alopecia, Diarrhoea, |
||||
ABEMACICLIB, ABEMACICLIB, |
||||
| 240 | 26509881 |
1 | ||
Alopecia, |
||||
QUIZARTINIB, |
||||
| 241 | 26509886 |
EU |
74 | 2 |
Alopecia, |
||||
OLMESARTAN MEDOXOMIL, EZETIMIBE, |
||||
| 242 | 26509899 |
US |
2 | |
Nail disorder, Alopecia, Muscle spasms, |
||||
OSIMERTINIB, |
||||
| 243 | 26510017 |
TW |
||
Toxicity to various agents, Embolism venous, Hypertension, Proteinuria, Radiation skin injury, Haemorrhage intracranial, Intracranial pressure increased, Skin toxicity, Alopecia, |
||||
BEVACIZUMAB, |
||||
| 244 | 26510094 |
CN |
51 | 2 |
Breast cancer recurrent, Metastasis, Drug resistance, Metastases to liver, Palmar-plantar erythrodysaesthesia syndrome, Diarrhoea, Nausea, Hepatic steatosis, Alopecia, Granulocytopenia, |
||||
PERTUZUMAB, TRASTUZUMAB, CAPECITABINE, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, DOCETAXEL, DOCETAXEL ANHYDROUS, |
||||
| 245 | 26510356 |
EU |
2 | |
Hospitalisation, Alopecia, |
||||
EXAGAMGLOGENE AUTOTEMCEL, |
||||
| 246 | 26510401 |
US |
62 | 1 |
Pain in extremity, Neuralgia, Muscle tightness, Alopecia, Myalgia, Blood pressure systolic increased, Arthralgia, Musculoskeletal stiffness, Red blood cell count decreased, White blood cell count decreased, Mobility decreased, |
||||
ENZALUTAMIDE, ENZALUTAMIDE, |
||||
| 247 | 26510695 |
US |
||
Alopecia, |
||||
PEMBROLIZUMAB, |
||||
| 248 | 26510733 |
IN |
41 | 1 |
Dysmorphism, Alopecia, Scar, Drug intolerance, Asthenia, |
||||
BRENTUXIMAB VEDOTIN, |
||||
| 249 | 26510829 |
US |
2 | |
Thyroid disorder, Tongue movement disturbance, Chest discomfort, Paraesthesia, Musculoskeletal disorder, Speech disorder, Dysphagia, Histamine abnormal, Panic attack, Alopecia, Foot deformity, Neuromuscular toxicity, |
||||
ONABOTULINUMTOXINA, |
||||
| 250 | 26511038 |
EU |
2 | |
Iridocyclitis, Blood glucose increased, Hyperkeratosis, Alopecia, Hypoaesthesia, Blood glucose increased, Blood pressure increased, |
||||
DABRAFENIB, DABRAFENIB, TRAMETINIB, TRAMETINIB, |
||||
| 251 | 26511164 |
US |
||
COVID-19 pneumonia, Illness, Alopecia, Product availability issue, Hypertension, |
||||
RUXOLITINIB, RUXOLITINIB, |
||||
| 252 | 26511425 |
US |
38 | 2 |
Somnolence, Nausea, Dizziness, Vomiting, Fatigue, Alopecia, Malnutrition, |
||||
TIRZEPATIDE, |
||||
| 253 | 26511621 |
US |
2 | |
Alopecia, Off label use, |
||||
| 254 | 26511751 |
US |
74 | 2 |
Constipation, Alopecia, |
||||
TIRZEPATIDE, |
||||
| 255 | 26511791 |
CA |
40 | 2 |
Abdominal distension, Arthralgia, Arthropathy, Back injury, Blepharospasm, Blister, Breast cancer stage III, Bursitis, Coeliac disease, Condition aggravated, Confusional state, Contusion, Depression, Dizziness, Drug hypersensitivity, Dry mouth, Duodenal ulcer perforation, Dyspepsia, Dyspnoea, Epilepsy, Facet joint syndrome, Fall, Fatigue, Fibromyalgia, Finger deformity, Folliculitis, Gait inability, Gastrointestinal disorder, Gastrooesophageal reflux disease, General physical health deterioration, Glossodynia, Hand deformity, Headache, Helicobacter infection, Hypercholesterolaemia, Hypersensitivity, Hypertension, Hypoaesthesia, Impaired healing, Inflammation, Infusion related reaction, Injection site reaction, Injury, Insomnia, Irritable bowel syndrome, Joint range of motion decreased, Joint swelling, Lip dry, Liver injury, Lung disorder, Memory impairment, Migraine, Mobility decreased, Muscle injury, Muscle spasms, Muscular weakness, Musculoskeletal pain, Musculoskeletal stiffness, Nail disorder, Nasopharyngitis, Neck pain, Night sweats, Obesity, Onychomadesis, Onychomycosis, Osteoarthritis, Pain, Pain in extremity, Paraesthesia, Pemphigus, Pericarditis, Peripheral swelling, Peripheral venous disease, Psoriatic arthropathy, Rheumatic fever, Rheumatoid arthritis, Sleep disorder, Stomatitis, Swelling, Synovitis, Systemic lupus erythematosus, Taste disorder, Type 2 diabetes mellitus, Urticaria, Wheezing, Wound, Wound infection, Abdominal pain upper, Alopecia, Asthenia, Diarrhoea, Lower respiratory tract infection, Hepatitis, Drug-induced liver injury, Hypotension, Malaise, Nausea, Pneumonia, Rash, Vomiting, Abdominal discomfort, |
||||
AZATHIOPRINE, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, CORTISONE ACETATE, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ERENUMAB-AOOE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, ATOMOXETINE HYDROCHLORIDE, BOTULINUM TOXIN TYPE A, BUPRENORPHINE, CANDESARTAN, CELECOXIB, CELECOXIB, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, LAMOTRIGINE, LAMOTRIGINE, MEPOLIZUMAB, |
||||
| 256 | 26511796 |
|||
Asthenia, Nystagmus, Tremor, Speech disorder, Alopecia, |
||||
BIMEKIZUMAB, |
||||
| 257 | 26511935 |
US |
33 | 2 |
Alopecia, Incorrect dose administered, |
||||
TIRZEPATIDE, |
||||
| 258 | 26503338 |
US |
2 | |
Alopecia, |
||||
TROFINETIDE, |
||||
| 259 | 26503617 |
US |
2 | |
Alopecia, |
||||
TIRZEPATIDE, |
||||
| 260 | 26503806 |
US |
75 | 2 |
Alopecia, Overdose, |
||||
MINOXIDIL, |
||||
| 261 | 26503885 |
US |
53 | 2 |
Alopecia, |
||||
TIRZEPATIDE, TIRZEPATIDE, |
||||
| 262 | 26504356 |
EU |
62 | 2 |
Limb operation, Emotional disorder, Trigger finger, Alopecia, |
||||
RISANKIZUMAB-RZAA, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE, METOPROLOL, |
||||
| 263 | 26504686 |
PH |
65 | 2 |
Haematotoxicity, Nail pigmentation, Alopecia, |
||||
DOXORUBICIN, CISPLATIN, ETOPOSIDE, |
||||
| 264 | 26505631 |
ZA |
39 | 2 |
Interferon gamma release assay positive, Paraesthesia, Tuberculin test positive, Alopecia, Influenza like illness, |
||||
CELECOXIB, METHOTREXATE, METHOTREXATE SODIUM, SULFASALAZINE, LEFLUNOMIDE, ADALIMUMAB, |
||||
| 265 | 26505793 |
US |
2 | |
Alopecia, |
||||
TIRZEPATIDE, TIRZEPATIDE, |
||||
| 266 | 26506097 |
EU |
50 | 1 |
Renal failure, Pyrexia, Chills, Erythema nodosum, Dry skin, Hyperkeratosis, Photosensitivity reaction, Hair texture abnormal, Alopecia, Myalgia, Illness, Abdominal pain upper, Asthenia, Pruritus, |
||||
DABRAFENIB, DABRAFENIB, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, |
||||
| 267 | 26506137 |
US |
88 | 2 |
Off label use, Alopecia, Gastrooesophageal reflux disease, |
||||
TIRZEPATIDE, TIRZEPATIDE, VITAMIN C, |
||||
| 268 | 26506887 |
EU |
69 | 2 |
Metastases to bone, Disease recurrence, Neoplasm malignant, Metastases to lung, Disease recurrence, Bronchitis, Dyspnoea, Dry mouth, Taste disorder, Peripheral swelling, Alopecia, Pollakiuria, Weight decreased, Osteoporosis, Musculoskeletal stiffness, Rhinorrhoea, Vision blurred, Speech disorder, Bone pain, Arthralgia, Joint stiffness, Fluid retention, Product blister packaging issue, Tongue dry, |
||||
RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, LETROZOLE, LETROZOLE TABLETS, |
||||
| 269 | 26507138 |
US |
||
Alopecia, |
||||
TIRZEPATIDE, |
||||
| 270 | 26507303 |
US |
2 | |
Abdominal pain upper, Skin hyperpigmentation, Onychalgia, Diarrhoea, Dry skin, Alopecia, Decreased appetite, Weight decreased, |
||||
OSIMERTINIB, |
||||
| 271 | 26507310 |
GB |
2 | |
Depressed mood, Alopecia, |
||||
TIRZEPATIDE, |
||||
| 272 | 26498250 |
US |
45 | 2 |
Alopecia, |
||||
TIRZEPATIDE, |
||||
| 273 | 26498488 |
US |
54 | 2 |
Febrile neutropenia, Alopecia, |
||||
POLATUZUMAB VEDOTIN, RITUXIMAB, PREDNISONE, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, DOXORUBICIN, |
||||
| 274 | 26498880 |
EU |
67 | 2 |
Shock, Thyroid disorder, Acne, Therapeutic product effect incomplete, Alopecia, Injection site pain, Product use in unapproved indication, |
||||
ETANERCEPT, ETANERCEPT, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, HYDROCORTISONE, |
||||
| 275 | 26499107 |
US |
||
Alopecia, |
||||
TIRZEPATIDE, |
||||
| 276 | 26499184 |
US |
72 | 2 |
Alopecia, |
||||
LENALIDOMIDE, ACYCLOVIR, ALPRAZOLAM, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, PROCHLORPERAZINE, SERTRALINE, |
||||
| 277 | 26499548 |
EU |
75 | 1 |
Malignant neoplasm progression, Erythema multiforme, Product use issue, Therapy partial responder, Alopecia, Asthenia, |
||||
ENFORTUMAB VEDOTIN, PEMBROLIZUMAB, |
||||
| 278 | 26499678 |
CA |
59 | 2 |
Muscle strain, Vulvovaginal burning sensation, Vulvovaginal pain, Head injury, Contusion, Ligament sprain, Joint swelling, Fall, Burning sensation, Arthralgia, Pain in extremity, Gait disturbance, Hypokinesia, Arthritis, Bowel movement irregularity, Urinary tract infection, Migraine, Migraine, Electric shock sensation, Seasonal allergy, Nasal congestion, Abdominal distension, Insomnia, Musculoskeletal discomfort, Joint range of motion decreased, Peripheral swelling, Peripheral coldness, Vitreous floaters, Poor venous access, Alopecia, Groin pain, Mobility decreased, Vision blurred, Visual impairment, Joint stiffness, Abdominal discomfort, Pain in extremity, Nausea, Hypoaesthesia, Abdominal pain, Paraesthesia, Pain, Fatigue, Headache, Incorrect drug administration rate, Nasopharyngitis, Oropharyngeal pain, Secretion discharge, Mass, Influenza, Pain, Skin swelling, Respiratory tract congestion, |
||||
AGALSIDASE BETA, AGALSIDASE BETA, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, SOTALOL HYDROCHLORIDE, PREGABALIN, METOPROLOL TARTRATE, METOPROLOL, COLCHICINE, BISOPROLOL FUMARATE, CANDESARTAN, NAPROXEN, NAPROXEN SODIUM, UBROGEPANT, UBROGEPANT, BACLOFEN, DIPHENHYDRAMINE HYDROCHLORIDE, |
||||
| 279 | 26499886 |
US |
52 | 2 |
Urticaria, Alopecia, |
||||
OMALIZUMAB, |
||||
| 280 | 26499927 |
US |
2 | |
Eye disorder, Hair texture abnormal, Thirst, Hypersensitivity, Bone density abnormal, Stress, Alopecia, Menopause, |
||||
DENOSUMAB, |
||||
| 281 | 26500011 |
EU |
27 | |
Alopecia, Psoriasis, |
||||
INFLIXIMAB, AZATHIOPRINE, |
||||
| 282 | 26500203 |
US |
23 | 2 |
Alopecia, |
||||
AVAPRITINIB, NORETHINDRONE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, PROCHLORPERAZINE, DIPHENHYDRAMINE HYDROCHLORIDE, LORATADINE, LORATADINE ORAL, FAMOTIDINE, EPINEPHRINE, ALBUTEROL SULFATE, |
||||
| 283 | 26500558 |
US |
68 | 2 |
Alopecia, |
||||
TIRZEPATIDE, |
||||
| 284 | 26500565 |
US |
2 | |
Alopecia, Folliculitis, |
||||
OCRELIZUMAB, |
||||
| 285 | 26500566 |
US |
56 | 2 |
Alopecia, Muscle spasms, Onychoclasis, Off label use, |
||||
TEPROTUMUMAB, TEPROTUMUMAB, |
||||
| 286 | 26500730 |
PE |
57 | 2 |
Hypotonia, Sicca syndrome, Osteoporosis postmenopausal, Zinc metabolism disorder, Gastroenteritis viral, Ill-defined disorder, Pain in extremity, Arthralgia, Hypothyroidism, Alopecia universalis, Osteoporosis, Alopecia, Therapy partial responder, Osteoporosis, Influenza, Pyrexia, Oropharyngeal pain, Sjogren^s syndrome, |
||||
TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, LEFLUNOMIDE, CARBOXYMETHYLCELLULOSE SODIUM, CARBOXYMETHYLCELLULOSE SODIUM, CARBOXYMETHYLCELLULOSE SODIUM, CARBOXYMETHYLCELLULOSE SODIUM, DEFLAZACORT, CELECOXIB, CELECOXIB, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, METHYLPREDNISOLONE, METHYLPREDNISOLONE, METHYLPREDNISOLONE, METHYLPREDNISOLONE, METHYLPREDNISOLONE, ZOLEDRONIC ACID, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, METHOTREXATE, METHOTREXATE SODIUM, |
||||
| 287 | 26500914 |
US |
79 | |
Blindness, Alopecia, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 288 | 26501243 |
|||
Pruritus, Alopecia, |
||||
BIMEKIZUMAB, |
||||
| 289 | 26501510 |
CA |
43 | 2 |
Systemic lupus erythematosus, Maternal exposure during pregnancy, Nasopharyngitis, Musculoskeletal pain, Alopecia, Hypertension, Pemphigus, Pericarditis, Inflammation, Arthropathy, Lower respiratory tract infection, Wheezing, Fatigue, Hand deformity, Facet joint syndrome, Obesity, Helicobacter infection, Mobility decreased, Duodenal ulcer perforation, Live birth, |
||||
SECUKINUMAB, SECUKINUMAB, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, ERENUMAB-AOOE, ERENUMAB-AOOE, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, CANDESARTAN, CANDESARTAN, CANDESARTAN, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, OXYCODONE, OXYCODONE, OXYCODONE, OXYCODONE, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, |
||||
| 290 | 26501976 |
US |
68 | 2 |
Pulmonary congestion, Biopsy bladder, Alopecia, Mobility decreased, Wheezing, Productive cough, Chronic obstructive pulmonary disease, Nasal congestion, Condition aggravated, Asthenia, Nausea, Weight decreased, |
||||
SEMAGLUTIDE, ORAL SEMAGLUTIDE, DUPILUMAB, DUPILUMAB, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, |
||||
| 291 | 26502076 |
CA |
2 | |
Anti-cyclic citrullinated peptide antibody positive, Abdominal discomfort, Alopecia, Arthralgia, Arthropathy, Blister, Condition aggravated, Confusional state, Contusion, Discomfort, Dyspnoea, Fatigue, Folliculitis, Gastrointestinal disorder, General physical health deterioration, Glossodynia, Drug ineffective, Drug intolerance, Contraindicated product administered, |
||||
SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, RITUXIMAB, RITUXIMAB, LEFLUNOMIDE, LEFLUNOMIDE, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, OXYCODONE, OXYCODONE, PREDNISOLONE ACETATE, OXYCODONE HYDROCHLORIDE, OXYCODONE, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, DICLOFENAC SODIUM, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, PREDNISONE, APREPITANT, APREPITANT, APREPITANT, APREPITANT, APREPITANT, APREPITANT, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CORTISONE ACETATE, CORTISONE ACETATE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, ETANERCEPT, ETANERCEPT, ETANERCEPT, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, INFLIXIMAB, GOLIMUMAB, USTEKINUMAB, SULFAMETHOXAZOLE AND TRIMETHOPRIM, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, USTEKINUMAB, USTEKINUMAB, TOFACITINIB, TOFACITINIB, TOFACITINIB, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, DEXAMETHASONE SODIUM PHOSPHATE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, SULFASALAZINE, SULFASALAZINE, |
||||
| 292 | 26502081 |
US |
66 | 2 |
Product dose omission in error, Alopecia, |
||||
ABEMACICLIB, |
||||
| 293 | 26506692 |
30 | 2 | |
Pain of skin, Alopecia, Product information content complaint, |
||||
LEVETIRACETAM, LEVETIRACETAM IN SODIUM CHLORIDE, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, |
||||
| 294 | 26497478 |
US |
71 | 2 |
Taste disorder, Alopecia, Constipation, Dysgeusia, |
||||
TIRZEPATIDE, ERGOCALCIFEROL, BIOTIN, MAGNESIUM, |
||||
| 295 | 26497662 |
US |
77 | 2 |
Drug ineffective, Weight fluctuation, Alopecia, |
||||
TIRZEPATIDE, |
||||
| 296 | 26497672 |
US |
59 | |
Dizziness, Weight decreased, Alopecia, Nausea, |
||||
TIRZEPATIDE, |
||||
| 297 | 26497681 |
US |
32 | 2 |
Illness, Alopecia, Rash, |
||||
DUPILUMAB, |
||||
| 298 | 26497716 |
US |
||
Alopecia, Drug ineffective, |
||||
TIRZEPATIDE, |
||||
| 299 | 26497804 |
PR |
54 | 2 |
Joint injury, Alopecia, Peripheral embolism, |
||||
ADALIMUMAB, ADALIMUMAB, DENOSUMAB, METHOTREXATE, METHOTREXATE SODIUM, |
||||
| 300 | 26496910 |
GB |
70 | 2 |
Raynaud^s phenomenon, Alopecia, Nausea, Brain fog, Constipation, Gastroenteritis viral, Migraine, |
||||
ATOGEPANT, ATOGEPANT, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, CITALOPRAM, CITALOPRAM HYDROBROMIDE, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-04-28